* Neximmune Inc NEXI.OQ reported a quarterly adjusted loss
of 60
cents per share for the quarter ended in September. The mean
expectation of four analysts for the quarter was for a loss
of 69 cents per share.
* Reported revenue was zero; analysts expected zero.
* Neximmune Inc's reported EPS for the quarter was a loss
of 60
cents.
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Neximmune Inc shares had fallen by 11.6% this quarter and
lost 89.4% so far this year.
* The company reported a quarterly loss of $14.73 million.
* Wall Street's median 12-month price target for Neximmune
Inc is
$3.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
14 at 10:22 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 -0.69 -0.60 Beat
Jun. 30 2022 -0.68 -0.69 Missed
Mar. 31 2022 -0.70 -0.66 Beat
Dec. 31 2021 -0.78 -0.69 Beat